Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

Virology

Volumn 271, Issue 2, 2000, Pages 264-275

  Hallak, Louay K ^a   Collins, Peter L ^b   Knudson, Warren ^a   Peeples, Mark E ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; GREEN FLUORESCENT PROTEIN; HEPARAN SULFATE; IDURONIC ACID; PROTAMINE SULFATE;

ARTICLE; CELL SURFACE; CHO CELL; CONTROLLED STUDY; GENE CONSTRUCT; GENE INSERTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN BINDING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TARGET CELL; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS PARTICLE;

CRICETINAE; CRICETULUS GRISEUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SYNCYTIAL VIRUS;

EID: 0034608222     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0293     Document Type: Article

References (80)

1. Backstrom G., Hook M., Lindahl U., Feingold D. S., Malmstrom A., Roden L., Jacobsson I. Biosynthesis of heparin: Assay and properties of the microsomal uronosyl C-5 epimerase. J. Biol. Chem. 254:1979;2975-2982.
2. Baulcombe D. C., Chapman S., Santa C. S. Jellyfish green fluorescent protein as a reporter for virus infections. Plant J. 7:1995;1045-1053.
3. Borders C. L. Jr., Raftery M. A. Purification and partial characterization of testicular hyaluronidase. J. Biol. Chem. 243:1968;3756-3762.
4. Bossennec V., Petitou M., Perly B. 1H-n.m.r. investigation of naturally occurring and chemically oversulphated dermatan sulphates. Identification of minor monosaccharide residues. Biochem. J. 267:1990;625-630.
5. Bourdon M. A., Krusius T., Campbell S., Schwartz N. B., Ruoslahti E. Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc. Natl. Acad. Sci. USA. 84:1987;3194-3198.
6. Bourgeois C., Bour J. B., Lidholt K., Gauthray C., Pothier P. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J. Virol. 72:1998;7221-7227.
7. Byrnes A. P., Griffin D. E. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:1998;7349-7356.
8. Byun Y., Singh V. K., Yang V. C. Low molecular weight protamine: A potential nontoxic heparin antagonist. Thromb. Res. 94:1999;53-61.
9. Casu B., Petitou M., Provasoli M., Sinay P. Conformational flexibility: A new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem. Sci. 13:1988;221-225.
10. Champe P. C., Harvey R. A. Glycosaminoglycans. Barnes D., Robinson S., Hoeltzel L. E. Biochemistry. 1987;81-89 J. B. Lippincott Company, Philadelphia.
11. Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., Marks R. M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate [see comments]. Nat. Med. 3:1997;866-871.
12. Chintala S. K., Miller R. R., McDevitt C. A. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Arch. Biochem. Biophys. 310:1994;180-186.
13. Chopra R. K., Pearson C. H., Pringle G. A., Fackre D. S., Scott P. G. Dermatan sulphate is located on serine-4 of bovine skin proteodermatan sulphate: Demonstration that most molecules possess only one glycosaminoglycan chain and comparison of amino acid sequences around glycosylation sites in different proteoglycans. Biochem. J. 232:1985;277-279.
14. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
15. Esko J. D., Raetz C. R. Replica plating and in situ enzymatic assay of animal cell colonies established on filter paper. Proc. Natl. Acad. Sci. USA. 75:1978;1190-1193.
16. Esko J. D., Zhang L. Influence of core protein sequence on glycosaminoglycan assembly. Curr. Opin. Struct. Biol. 6:1996;663-670.
17. Esko J. D., Rostand K. S., Weinke J. L. Tumor formation dependent on proteoglycan biosynthesis. Science. 241:1988;1092-1096.
18. Esko J. D., Stewart T. E., Taylor W. H. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA. 82:1985;3197-3201.
19. Esko J. D., Weinke J. L., Taylor W. H., Ekborg G., Roden L., Anantharamaiah G., Gawish A. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J. Biol. Chem. 262:1987;12189-12195.
20. Feldman S. A., Hendry R. M., Beeler J. A. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73:1999;6610-6617.
21. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., Eriksson I., Ledin J., Hellman L., Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme [In Process Citation]. Nature. 400:1999;773-776.
22. Godavarti R., Sasisekharan R. Heparinase I from Flavobacterium heparinum: Role of positive charge in enzymatic activity. J. Biol. Chem. 273:1998;248-255.
23. Greve H., Cully Z., Blumberg P., Kresse H. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J. Biol. Chem. 263:1988;12886-12892.
24. Heminway B. R., Yu Y., Tanaka Y., Perrine K. G., Gustafson E., Bernstein J. M., Galinski M. S. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology. 200:1994;801-805.
25. Hsiao J. C., Chung C. S., Chang W. Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: Identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain. J. Virol. 72:1998;8374-8379.
26. Hsiao J. C., Chung C. S., Chang W. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:1999;8750-8761.
27. Hubbard A. R., Jennings C. A. Neutralisation of heparan sulphate and low molecular weight heparin by protamine. Thromb. Haemost. 53:1985;86-89.
28. Jackson T., Ellard F. M., Ghazaleh R. A., Brookes S. M., Blakemore W. E., Corteyn A. H., Stuart D. I., Newman J. W., King A. M. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:1996;5282-5287.
29. Jacobsson K. G., Lindahl U., Horner A. A. Location of antithrombin-binding regions in rat skin heparin proteoglycans. Biochem. J. 240:1986;625-632.
30. Johnson P. R., Spriggs M. K., Olmsted R. A., Collins P. L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA. 84:1987;5625-5629.
31. Karamanos N. K., Vanky P., Syrokou A., Hjerpe A. Identity of dermatan and chondroitin sequences in dermatan sulfate chains determined by using fragmentation with chondroitinases and ion- pair high-performance liquid chromatography. Anal. Biochem. 225:1995;220-230.
32. Karron R. A., Buonagurio D. A., Georgiu A. F., Whitehead S. S., Adamus J. E., Clements-Mann M. L., Harris D. O., Randolph V. B., Udem S. A., Murphy B. R., Sidhu M. S. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA. 94:1997;13961-13966.
33. Klimstra W. B., Ryman K. D., Johnston R. E. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:1998;7357-7366.
34. Knudson C. B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7:1993;1233-1241.
35. Kokenyesi R., Bernfield M. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J. Biol. Chem. 269:1994;12304-12309.
36. Kovensky J., Duchaussoy P., Bono F., Salmivirta M., Sizun P., Herbert J. M., Petitou M., Sinay P. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers. Bioorg. Med. Chem. 7:1999;1567-1580.
37. Krusat T., Streckert H. J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1997;1247-1254.
38. Langedijk J. P., Schaaper W. M., Meloen R. H., van Oirschot J. T. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J. Gen. Virol. 77:1996;1249-1257.
39. Levine S., Klaiber-Franco R., Paradiso P. R. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:1987;2521-2524.
40. Lidholt K., Weinke J. L., Kiser C. S., Lugemwa F. N., Bame K. J., Cheifetz S., Massague J., Lindahl U., Esko J. D. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. USA. 89:1992;2267-2271.
41. Lindahl U. Approaches to the synthesis of heparin. Haemostasis. 20:1990a;146-153.
42. Lindahl U. Biosynthesis of heparin. Biochem. Soc. Trans. 18:1990b;803-805.
43. Lindahl U., Feingold D. S., Roden L. Biosynthesis of heparin. Trends Biochem. Sci. 11:1986;221-225.
44. Lindahl U., Kusche M., Lidholt K., Oscarsson L. G. Biosynthesis of heparin and heparan sulfate. Ann. NY Acad. Sci. 556:1989;36-50.
45. Linhardt R. J., al Hakim A., Liu J. A., Hoppensteadt D., Mascellani G., Bianchini P., Fareed J. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem. Pharmacol. 42:1991;1609-1619.
46. Lohse D. L., Linhardt R. J. Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem. 267:1992;24347-24355.
47. Lories V., de Boeck H., David G., Cassiman J. J., Van Den B. H. Heparan sulfate proteoglycans of human lung fibroblasts: Structural heterogeneity of the core proteins of the hydrophobic cell-associated forms. J. Biol. Chem. 262:1987;854-859.
48. Maccarana M., Sakura Y., Tawada A., Yoshida K., Lindahl U. Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 271:1996;17804-17810.
49. Michelacci Y. M., Dietrich C. P. A comparative study between a chondroitinase B and a chondroitinase AC from Flavobacterium heparinum: Isolation of a chondroitinase AC- susceptible dodecasaccharide from chondroitin sulphate B. Biochem. J. 151:1975;121-129.
50. Mondor I., Ugolini S., Sattentau Q. J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:1998;3623-3634.
51. Nackaerts K., Verbeken E., Deneffe G., Vanderschueren B., Demedts M., David G. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int. J. Cancer. 74:1997;335-345.
52. Nahmias A. J., Kibrick S. Inhibitory effect of heparin on herpes simplex virus. J. Bacteriol. 87:1964;1060-1066.
53. Ohya T., Kaneko Y. Novel hyaluronidase from streptomyces. Biochim. Biophys. Acta. 198:1970;607-609.
54. Pastey M. K., Samal S. K. Analysis of bovine respiratory syncytial virus envelope glycoproteins in cell fusion. J. Gen. Virol. 78:1997;1885-1889.
55. Perlin A. S. Recent Structural Studies on Heparin. McDuffie N. M. Heparin: Structure, Cellular Functions, and Clinical Applications. 1979;25-37 Academic Press, San Diego.
56. Piepkorn M. W., Lagunoff D., Schmer G. Heparin binding to antithrombin III: Variation in binding sites and affinity. Biochem. Biophys. Res. Commun. 85:1978;851-856.
57. Portelli J., Gordon A., May J. T. Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro. J. Med. Microbiol. 47:1998;1015-1018.
58. Schmid K., Grundboeck-Jusco J., Kimura A., Tschopp F. A., Zollinger R., Binette J. P., Lewis W., Hayashi S. The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging. Biochim. Biophys. Acta. 716:1982;178-187.
59. Shieh M. T., WuDunn D., Montgomery R. I., Esko J. D., Spear P. G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1992;1273-1281.
60. Shukla D., Liu J., Blaiklock P., Shworak N. W., Bai X., Esko J. D., Cohen G. H., Eisenberg R. J., Rosenberg R. D., Spear P. G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99:1999;13-22.
61. Sie P., Cremers B., Dupouy D., Caranobe C., Dol F., Boneu B. Neutralization of dermatan sulfate in vitro and in vivo by protamine sulfate and polybrene. Thromb. Res. 54:1989;63-74.
62. Silbert C. K., Humphries D. E., Palmer M. E., Silbert J. E. Effects of sulfate deprivation on the production of chondroitin/dermatan sulfate by cultures of skin fibroblasts from normal and diabetic individuals. Arch. Biochem. Biophys. 285:1991;137-141.
63. Spear P. G., Shieh M. T., Herold B. C., WuDunn D., Koshy T. I. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313:1992;341-353.
64. Suzuki S., Saito H., Yamagata T., Anno K., Seno N., Kawai Y., Furuhashi T. Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J. Biol. Chem. 243:1968;1543-1550.
65. Tekotte H., Engel M., Margolis R. U., Margolis R. K. Disaccharide composition of heparan sulfates: Brain, nervous tissue storage organelles, kidney, and lung. J. Neurochem. 62:1994;1126-1130.
66. Toida T., Yoshida H., Toyoda H., Koshiishi I., Imanari T., Hileman R. E., Fromm J. R., Linhardt R. J. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem. J. 322:1997;499-506.
67. Turnbull J. E., Fernig D. G., Ke Y., Wilkinson M. C., Gallagher J. T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267:1992;10337-10341.
68. Underhill C. CD44: The hyaluronan receptor. J. Cell Sci. 103:1992;293-298.
69. van Kuppevelt T. H., Cremers F. P., Domen J. G., Kuyper C. M. Staining of proteoglycans in mouse lung alveoli. II. Characterization of the Cuprolinic blue-positive, anionic sites. Histochem. J. 16:1984;671-686.
70. van Kuppevelt T. H., Cremers F. P., Domen J. G., van Beuningen H. M., van den Brule A. J., Kuyper C. M. Ultrastructural localization and characterization of proteoglycans in human lung alveoli. Eur. J. Cell Biol. 36:1985;74-80.
71. Walsh E. E., Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: Identification of the fusion protein. J. Virol. 47:1983;171-177.
72. Walter A., Downing L. A. Respiratory syncytial virus interactions with host cell membranes: An enigma among the paramyxoviridae. Bentz J. Viral Fusion Mechanisms. 1993;363-383 CRC Press, Inc. Boca Raton.
73. Westergren-Thorsson G., Onnervik P. O., Fransson L. A., Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate- containing glycosaminoglycans. J. Cell. Physiol. 147:1991;523-530.
74. Westergren-Thorsson G., Persson S., Isaksson A., Onnervik P. O., Malmstrom A., Fransson L. A. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp. Cell Res. 206:1993;93-99.
75. Whitfield D. M., Choay J., Sarkar B. Heavy metal binding to heparin disaccharides. I. Iduronic acid is the main binding site. Biopolymers. 32:1992;585-596.
76. WuDunn D., Spear P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.
77. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.
78. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243:1968;1523-1535.
79. Zhang L., David G., Esko J. D. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J. Biol. Chem. 270:1995;27127-27135.
80. Zhang L., Esko J. D. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J. Biol. Chem. 269:1994;19295-19299.